Copyright
©The Author(s) 2021.
World J Gastroenterol. Mar 7, 2021; 27(9): 866-885
Published online Mar 7, 2021. doi: 10.3748/wjg.v27.i9.866
Published online Mar 7, 2021. doi: 10.3748/wjg.v27.i9.866
Figure 4 Receiver operating characteristic curves illustrating the diagnostic ability of serum beta-glucan for detecting disease activity in patients with ulcerative colitis.
Receiver operating characteristic curves are shown in relation to the (A) clinical; (B) endoscopic; (C) histologic; and (D) combined endoscopic and histologic criteria. Diagonal segments are produced by ties. The area under the curve with standard error and the 95% confidence interval (95%CI) are shown in each plot.
- Citation: Farias e Silva K, Nanini HF, Cascabulho CM, Rosas SLB, Santana PT, Carneiro AJV, Anaissie E, Nucci M, de Souza HSP. Serum 1,3-beta-D-glucan as a noninvasive test to predict histologic activity in patients with inflammatory bowel disease. World J Gastroenterol 2021; 27(9): 866-885
- URL: https://www.wjgnet.com/1007-9327/full/v27/i9/866.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i9.866